Danqi Wang

机构：Jiangnan University, Central South University, Wenzhou Medical University, Wuhan University, Wuxi Fourth People's Hospital, Zhongnan Hospital of Wuhan University, Imperial College London · ORCID：0009-0001-7656-9901

发表论文 67 篇 · 总被引 1446 次 · h-index 22

代表论文

• Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021 (2024 · Military Medical Research · 被引 152)
• Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial (2024 · The Lancet · 被引 86)
• Fecal transplant from myostatin deletion pigs positively impacts the gut-muscle axis (2023 · eLife · 被引 37)
• Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease (2024 · Journal of the American College of Cardiology · 被引 36)
• Characterization of an exopolysaccharide synthesized by Lacticaseibacillus rhamnosus B6 and its immunomodulatory activity in vitro (2024 · International Journal of Biological Macromolecules · 被引 24)
• Downregulation of N6-methyladenosine-modified LINC00641 promotes EMT, but provides a ferroptotic vulnerability in lung cancer (2023 · Cell Death and Disease · 被引 21)